MEGGLE Excipients & Technology at Drug Delivery to the Lungs (DDL) 2019 in Edinburgh!

Pharmaceutical lactose specialist MEGGLE Excipients &Technology (MEGGLE) will attend the DDL Conference 2019 in Edinburg to present two new products suitable for use in pulmonary and nasal drug delivery.

MEGGLE Excipients & Technology rounds up the portfolio for dry powder inhalation with the new milled lactose grades InhaLac® 140 and InhaLac® 150. The two new inhalative lactose grades with specific particle size distributions are characterized by the typical flow- and surface-characteristic of milled lactose grades. This provides an additional tool for the formulator to tune and optimize the performance of the DPI product. As middle-sized milled carrier lactose, InhaLac 140 and InhaLac 150 are suitable for use in pulmonary and nasal drug delivery.

More information at DDL 2019 and

Drop by at our booth 224 to learn more about our high functional excipients.

DDL 2019 – Opening hours

  • December 11th 2019 – 11:00 – 18:00
  • December 12th 2019 – 09:00 – 17:45
  • December 13th 2019 – 09:00 – 13:00

Download the Full Programm [pdf]


DDL Conference 2019

The Exchange Edinburgh,
EH3 8EE,
United Kingdom

​​​​​​​Further information on the conference venue:

Tickets – DDL 2019

Simply click here to buy your ticket via the official website!

DDL_2019_Meggle_New Products_InhaLac 140_InhaLac 150

Let´s meet in Edinburgh

If you would like to meet one of the MEGGLE staff during CPhI worldwide in Frankfurt, please feel free to contact us via in order to set up a meeting.